METHOD OF PRODUCING AGENT, BINDING WITH PRE-VASOPRESSIN OR ITS FRAGMENTS Russian patent published in 2017 - IPC G01N33/68 G01N33/74 

Abstract RU 2607588 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine and method of producing binding agent or mixture of binding agents, capable to bind with epitope, contained in amino acid sequence, corresponding to C-end part of pre-vasopressin, consisting of amino acids 146-163, but not containing amino acid 164, where said method includes steps of producing binding agent with help of forming agent; determination binding ability of binding agent with amino acid sequence with length of at least 12 amino acids, contained in amino acid sequence, corresponding to C-end part, but not containing amino acid 164 of pre-vasopressin; selection of binding agent from multitude of binding agents. Group of inventions also relates to forming agent for producing binding agent or mixture of binding agents; application of binding agent for qualitative or quantitative detection of pre-vasopressin or its fragments in biological sample.

EFFECT: group of inventions provides qualitative or quantitative detection of pre-vasopressin or its fragments in biological sample.

20 cl, 1 ex, 5 dwg, 2 tbl

Similar patents RU2607588C2

Title Year Author Number
NEW BINDING MOLECULES WITH ANTI-TUMOUR ACTIVITY 2013
  • Brak Simon
  • Murlan Frederik
  • Toller Izabella
  • Vuds Richard
  • Bertshinger Yulian
  • Grabulovski Dragan
  • Shade Babette
  • Klupsh Kristina
  • Khakhemi Khelen
RU2627185C1
MOLECULAR MIMETICS OF MENINGOCOCCUS B EPITOPE THAT INDUCE PRODUCTION OF FUNCTIONALLY ACTIVE ANTIBODY 2002
  • Granoff Dehn
  • Moeh Gregori
  • Rappuoli Rino
RU2322451C2
BIOMARKERS FOR DIAGNOSIS, PREDICTION, ASSESSMENT AND STRATIFICATION OF FAINTING THERAPY 2013
  • Shtruk Joakhim
  • Melander Olle
  • Fedorovski Artur
RU2613885C2
MONOCLONAL ANTIBODY DIRECTED AGAINST GNA33 PEPTIDE AND ITS APPLICATION 2002
  • Granoff Dehn
  • Moeh Gregori
  • Rappuoli Rino
RU2355704C2
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM 2009
  • Chehn', Ivonne
  • Dennis, Mark
  • Dornan, Dehvid
  • Ehlkins, Kristi
  • Dzhunutula, Dzhagatkh, Reddi
  • Polson, Ehndrju
  • Chzhehn, Bin
RU2553566C2
PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2013
  • Girsdorf Sven
  • Tamm Mikhael
  • Shtolts Dajana
RU2688168C2
gp41-NEUTRALIZING ANTIBODIES AND THEIR APPLICATION 2012
  • Konnors Mark
  • Khuan Tszinkhe
  • Laub Leo B.
  • Kvong Piter
  • Nejbel Gari
  • Maskola Dzhon R.
  • Chzhan Baoshan
  • Rudisell Rebekka S.
  • Dzhordzhiv Ivelin
  • Yang Jongping
  • Chzhu Tszyan
  • Ofek Dzhilad
RU2624046C2
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM 2008
  • Chehn' Ivonn
  • Dennis Mark
  • Dornan Dehvid
  • Ehlkins Kristi
  • Dzhunutula Dzhagatkh Reddi
  • Polson Ehndrju
  • Chzhehn Bin
RU2511410C2
COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITES DEGENERATION 2013
  • Myuller Bernkhard
  • Khuang Lili
  • Barduell Filip D.
  • Kutskova Yuliya
  • Memmott Dzhon
RU2644337C2
USING ANTI-TAU PS422 ANTIBODY FOR TREATING CEREBROPATHIES 2010
  • Borman Bernd
  • Gepfert Ul'Rikh
  • Grjuehninger Fiona
  • Khuber Val'Ter
  • Krell' Khans-Villi
  • Lifke Valeria
  • Mundigl' Olaf
  • Offner Zonja
  • Ozmen Lorens
  • Shreml' Mikhel'
RU2536247C2

RU 2 607 588 C2

Authors

Shtruk Joakhim

Dates

2017-01-10Published

2012-06-26Filed